Teladoc Health, Inc.

NYSE:TDOC

Medical - Healthcare Information Services

Healthcare
$8.06 +2.57%

+$0.20 today

Market cap
$1.47B
Beta
2.14
P/E (TTM)
-8.1
EPS (TTM)
-$0.96
52W Low $4.40High $9.77

Volume 3.96M

Average 4.68M

TDOC Gross Margin

Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.

Teladoc Health, Inc.NYSE: TDOC

Gross Margin · Q1 FY2026 · quarter ended Mar 2026

Gross margin narrows to 52.8%

Gross margin was 52.8% in Q1 FY2026, down 15.9 pp from a year earlier. On a trailing-twelve-month basis it was 65.6%, down 4.9 pp year over year. Over 3 fiscal years it widened by 0.4 pp.

Context

  • Gross margin widened in 1 of the last 3 fiscal years.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
52.8%-16.5 pp QoQ
Last fiscal yearDec 2025
69.5%-1.3 pp YoY
LTMMar 2026
65.6%-4.9 pp YoY
Gross Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter-15.9 pp——
1 year-1.3 pp——
3 years+0.4 pp——
5 years——
10 years——

Gross Margin history

Percent of revenue · from the income statement

Latest · FY2025
69.5%
Year-over-year change
-1.3pp

Gross Margin vs competitors

How TDOC compares with its peers on the latest reported figures

  • TDOC's LTM Mar 2026 gross margin of 65.6% is the 4th highest of the 10 companies compared; the peer median is 57.4%.
  • Its year-over-year change of -4.9 pp is the 9th highest of 10, against a peer median of -2.0 pp.
  • Over three fiscal years its change of +0.4 pp compares with a peer median of +1.1 pp.
TDOC Competitors Peer median
Gross Margin for TDOC and competitors
Company Period LTM level YoY 3-year change
NVCRNovoCure LimitedLTM Mar 202675.2% -2.0 pp-4.1 pp
OMDAOmada HealthLTM Mar 202666.2% +4.6 pp+17.7 pp
PHRPhreesia, Inc.LTM Apr 202665.8% -2.2 pp+6.8 pp
TDOCTeladoc Health, Inc.LTM Mar 202665.6% -4.9 pp+0.4 pp
SDGRSchrödinger, Inc.LTM Sep 202658.5% +0.4 pp-0.1 pp
IMNMImmunome, Inc.FY202557.4% -42.6 pp—
AZTAAzenta, Inc.LTM Sep 202644.2% -2.0 pp+9.2 pp
OMCLOmnicell, Inc.LTM Mar 202643.5% +0.3 pp-2.6 pp
PGNYProgyny, Inc.LTM Jun 202624.6% +2.2 pp+2.4 pp
EVOEvotec SELTM Mar 202611.4% -2.3 pp-14.9 pp
PHVSPharvaris N.V.FY2025— ——
Peer median (excluding TDOC) 57.4%-2.0 pp+1.1 pp

Competitors are the stored peer set for TDOC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue2.03B2.41B2.6B2.57B2.53B
Cost of Revenue650.26M743.99M760.03M751.27M771.59M
Gross Profit1.38B1.66B1.84B1.82B1.76B
Gross Margin68.0%69.1%70.8%70.8%69.5%
Research & Development311.88M333.63M348.52M307.27M277.92M
Selling, General & Admin1.11B1.3B1.37B1.35B1.09B
Operating Expenses1.65B15.32B2.09B2.84B2.02B
Depreciation & Amortization207.57M209.93M254.11M240.51M363.12M
EBITDA(31.42M)(7.54M)43.61M31.72M147.3M
EBITDA Margin-1.5%-0.3%1.7%1.2%5.8%
Operating Income(265.63M)(13.65B)(248.55M)(1.02B)(262.96M)
Operating Margin-13.1%-567.3%-9.6%-39.7%-10.4%
Interest Income776K12.67M46.78M57.07M36.77M
Interest Expense81.14M21.94M22.28M23.8M19.71M
Other Income / Expenses(119.03M)(10.13M)28.95M27.23M27.43M
Income Before Tax(384.66M)(13.66B)(219.61M)(993.65M)(235.53M)
Pre-Tax Margin-18.9%-567.7%-8.4%-38.7%-9.3%
Income Tax Expense44.14M(3.81M)760K7.59M(35.21M)
Net Income(428.79M)(13.66B)(220.37M)(1B)(200.32M)
Net Margin-21.1%-567.5%-8.5%-39.0%-7.9%
EPS (Basic)(2.73)(84.60)(1.36)(5.87)(1.14)
EPS (Diluted)(2.73)(84.60)(1.34)(5.87)(1.14)
Weighted Avg Shares156.94M161.46M162.17M170.56M176.22M
Weighted Avg Shares (Diluted)156.94M161.46M164.58M170.56M176.22M

Teladoc Health, Inc.

NYSE:TDOC

Intrinsic Alpha fair value

Locked

Current Price

$8.06

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.